ATG9A Polyclonal Antibody


Catalog Number Pack Size List Price* Quantity
PA116993 100 µL 600,00 Add

* CHF, excl. 8.1% VAT and shipping costs


Product Description

Macroautophagy is the major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells, it is also responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation. Macroautophagy involves the formation of double-membrane bound autophagosomes which enclose the cytoplasmic constituent targeted for degradation in a membrane bound structure, which then fuse with the lysosome (or vacuole) releasing a single-membrane bound autophagic bodies which are then degraded within the lysosome (or vacuole). Apg9 plays a direct role in the formation of the cytoplasm to vacuole targeting and autophagic vesicles, possibly serving as a marker for a specialized compartment essential for these vesicle-mediated alternative targeting pathways.

Category Antibody
Supplier ThermoFisher
Application FC, ICC, IHC, IP, WB
Regulatory Status RUO
Immunogen Synthetic peptide corresponding to residues 750-839 of human ATG9A.
Host Rb
Genebank ATG9A
Isotype IgG
Crossreactivity Bo, Ck, Drosophila, Hu, Ms, Primate, Rt, Reptile
Clonality Pab
Format Liquid; PBS; , with 0.02% sodium azide
Concentration 1 mg/mL
Working Dilution Immunocytochemistry (2 µg/mL), Western Blot (1-3 µg/mL), Immunohistochemistry (Paraffin) (1:100-1...
Purity Antigen affinity chromatography
Conjugation Unconjugated
Storage Conditions -20° C, Avoid Freeze/Thaw Cycles
Disclaimer Alternative CatNo: PA1-16993
Tech. Data Sheet View datasheet
Link To Supplier https://www.thermofisher.com
Material Safety Data Sheet Download PDF